Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Veranova announced the appointment of Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence. Ms. Rebeil brings more than 20 years of experience in supply chain management and continuous improvement within the ...
read more
Piramal Pharma Limited has announced a $90M investment plan towards expanding two of the Company’s US facilities. These expansions are in response to ongoing demand from US customers, in support of the trend towards US onshoring of drug supply, and ...
read more
Amneal Pharmaceuticals and Apiject Systems announced a strategic collaboration to expand domestic production of Apiject’s BFS-based injectable platform at Amneal’s Brookhaven, NY facility. The collaboration will enable large-scale capacity to produce...
read more
Bionova Scientific announced it has licensed ATUM's proprietary Leap-In Transposase® transposon-based gene delivery and its miCHO™ cell line development technologies.
read more
Tobin Scientific announced that it has closed a significant capital raise to support its next phase of growth. Denali Growth Partners and Truck 9 Partners led the minority growth equity investment, and Eastern Bank provided a comprehensive financing ...
read more
Aenova announced the launch of its AenovationTM program. This program is designed to fast-track early development of pharmaceutical formulations, specifically addressing the critical challenges of bioavailability and time-to-market for poorly soluble...
read more
Hovione and Firstgene Life Sciences announced a strategic collaboration to advance Hovione’s proprietary virus-like particle drug delivery platform for the targeted treatment of Hepatocellular Carcinoma (HCC), a therapeutic indication developed by ...
read more
Celerion announced the launch of the latest version of Labnotes, its bioanalytical electronic laboratory notebook software for data handling and analysis capabilities for sponsors.
read more
Transpire Bio has signed an agreement to expand the footprint of its R&D and Manufacturing capabilities in Pembroke Pines, Florida. The expansion is expected to enhance and build upon the company’s existing R&D and Commercial Manufacturing operations...
read more
Vetter has published its fourth annual sustainability report. The report shows that the family-owned business is actively pursuing ambitious sustainability goals in climate protection, social responsibility, and business operations in a successful ...
read more
Summit Clinical Research has successfully completed a strategic investment in Houston Research Institute and strengthened its executive team with the appointment of Dr. Mazen Noureddin as Co-Chairman of Summit's Board of Directors and the additions ...
read more
Crown Bioscience announced the extension of its partnership with NEXT Oncology. This partnership will continue to leverage Crown Bioscience's experience in developing clinically relevant cancer organoid and patient-derived xenograft (PDX) models, ...
read more
Univar Solutions has been appointed the preferred distributor for Tedia Company's high-purity solvents and ultra-high purity (UHP) oligonucleotide and peptide synthesis (ONS) chemicals in the United States and Canada for pharmaceutical and ...
read more
Bespak announced that it has completed its first life cycle assessment (LCA) for its BK357 pressurized Metered Dose Inhaler (pMDI) valve. This important step comes as a result of Bespak’s commitment to looking beyond low Global Warming Potential (GWP...
read more
The company announced its successful approval by the FDA for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (...
read more